ALB and breast carcinoma: Three taxane-based reagents are widely used as first-line treatment for patients with breast cancer, that is, paclitaxel formulated with either CrEL (Taxol) or solvent-free, albumin nanoparticles (Abraxane) and docetaxel formulated with polysorbate (Taxotere).